STAT1 and neoplasm: To further verify whether the STAT1/STAT3 signaling pathway was involved in macrophages protecting tumor cells from CAP treatment, Fludarabine (STAT1 transcription inhibitor) or Stattic (STAT3 phosphorylation inhibitor) was employed to treat Calu-1 cells.